Ihara Kumiko, Unei Hiroko, Iwasaki Yasumasa, Yashiki Mikio, Tanigawa Koichi, Kihira Kenji, Ozawa Koichiro
Department of Pharmacotherapy, Graduate School of Biomedical Sciences, Hiroshima University.
Chudoku Kenkyu. 2003 Oct;16(4):433-40.
We have developed guidelines of pharmaceutical activity which describes how pharmacists are actively involved in supporting the initial treatment of poisoning and overdosed patients in the Intensive Care Unit (ICU). These guidelines are derived from the original procedural manual that consisted of protocol charts. The charts provide the pharmacist including ICU staff members with directions for the collection of clinical information and the forms to use for documentation. We focused on appropriate collection and proper preservation of collected samples in order to perform diagnostic analysis when needed. The original Information Record Form, completed by the participating pharmacist, documents all information regarding the patient's care. This record provides for integration of the diverse and complicated clinical information of the patient so that the physician can gain a comprehensive picture of the patient. The guidelines, manual book, materials for sample collection and the Information Record Form are stored in a container called the "Poisoning Aid Set", which will be available in the ICU. The guidelines are activated once an emergency call from paramedics is received regarding a suspected poisoning patient. According to the guidelines, the emergency room (ER) physician immediately contacts the pharmacist who will provide his professional services as a member of the treatment team. We have applied these guidelines to 29 poisoning patients and have critically evaluated for effectiveness. Early participation by pharmacists, by reviewing timely, accurate and competent clinical information enabled the pharmacist to identify the suspected drug from the biological samples obtained. From our experiences, we conclude that this active involvement of pharmacist in the initial treatment of poisoning and overdosed patients in the ICU was both supportive and beneficial to the patient. In addition, the participation of pharmacist as a member of a treatment team provided an excellent opportunity to collaborate with the entire ICU staff members.
我们制定了药物活性指南,该指南描述了药剂师如何积极参与支持重症监护病房(ICU)中毒和用药过量患者的初始治疗。这些指南源自最初由方案图表组成的程序手册。这些图表为药剂师及ICU工作人员提供了收集临床信息的指导以及用于记录的表格。我们着重于适当收集和妥善保存所采集的样本,以便在需要时进行诊断分析。由参与的药剂师填写的原始信息记录表记录了有关患者护理的所有信息。该记录有助于整合患者多样且复杂的临床信息,从而使医生能够全面了解患者情况。指南、手册、样本收集材料和信息记录表存放在一个名为“中毒援助套装”的容器中,该套装将在ICU中提供。一旦接到护理人员关于疑似中毒患者的紧急呼叫,指南即被启用。根据指南,急诊室(ER)医生会立即联系药剂师,药剂师将作为治疗团队的一员提供专业服务。我们已将这些指南应用于29名中毒患者,并对其有效性进行了严格评估。药剂师通过及时、准确且专业地审查临床信息而尽早参与,能够从所获得的生物样本中识别出疑似药物。根据我们的经验,我们得出结论,药剂师在ICU中毒和用药过量患者的初始治疗中的这种积极参与对患者既具有支持作用又有益处。此外,药剂师作为治疗团队成员的参与为与整个ICU工作人员合作提供了绝佳机会。